This inventor holds 21 USPTO granted patents and 2 published patent applications and 3 EPO patents, primarily in Antibody Therapeutics. Top assignees: Millennium Pharmaceuticals Limited, Bikam Pharmaceuticals Inc., Millenium Pharmaceuticals, Inc.. Active years: 2001-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- West Roxbury, MA (US) (2001 - 2002)
- W. Roxbury, MA (US) (2002)
- Waban, MA (US) (2002)
- Newton, MA (US) (2004 - 2017)
Company Filing History:
16 out of 855 
2 out of 7 
1 out of 36 Years Active: 2001-2017
Areas of Expertise:
Title: Innovations of Gregory J. LaRosa: Pioneering Ophthalmic Research
Introduction: Gregory J. LaRosa is an accomplished inventor based in Newton, MA, known for his significant contributions to the field of ophthalmic research. With a remarkable portfolio of 21 patents, LaRosa has dedicated his career to addressing critical issues related to vision and eye health. His innovative approaches have paved the way for new treatments aimed at improving the lives of individuals affected by various ophthalmic conditions.
Latest Patents: Among his most recent innovations are the patents for opsin-binding ligands, which detail compounds and methodologies designed to treat ophthalmic conditions associated with the mislocalization and misfolding of opsin proteins. These patents encompass the use of therapeutics to handle the accumulation of toxic visual cycle products in the eye. Specifically, his inventions target ailments such as dry age-related macular degeneration, ensuring therapeutic strategies are developed either independently or in conjunction with other agents. The methods for synthesizing these compounds further illustrate LaRosa's commitment to advancing treatment options for complex eye conditions.
Career Highlights: Throughout his career, Gregory J. LaRosa has made significant strides in the pharmaceutical industry. His tenure includes working with renowned organizations such as Millennium Pharmaceuticals Limited, where he contributed to groundbreaking research and development initiatives. His expertise and innovative mindset have secured his reputation as a leading inventor in his field.
Collaborations: LaRosa has collaborated with several distinguished professionals, including Christopher Horvath and Walter Newman. These partnerships have facilitated the exchange of ideas and fostered a collaborative environment that promotes the advancement of innovative solutions in eye care.
Conclusion: Gregory J. LaRosa stands out as a notable inventor whose work has led to significant advancements in ophthalmic research. With a portfolio of patents that demonstrate his innovative spirit, LaRosa continues to play a vital role in developing effective treatments for ocular conditions. His contributions not only enhance the understanding of eye disorders but also inspire future research and development within the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile